Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UMSC01 as an Add-On Treatment for Acute STEMI
NCT06147986Phase 2Recruiting
- Sponsor
- Ever Supreme Bio-Technology
- Start
- Sep 2023
- Primary completion
- Jun 2027
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord derived mesenchymal stem cells in ST elevation myocardial infarction (STEMI), sponsored by Ever Supreme Bio-Technology. Started Sep 2023; status: recruiting.
02
Drugs
human umbilical cord derived mesenchymal stem cells
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT06147986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06147986.